FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Sep 7, 2018
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on September 7, 2018, issued by the Florida District Office, covering biologics.
- Office
- Florida District Office
- People
- Barbara G. Peoples (Issuing Officer)
- Colleen M. Aspinwall (Issuing Officer)
View Company Profile
ID · 436bb5f4-1ed5-4c6f-8d06-d42444bacc5b
Inspection Facts
- Inspection number
- 1070541
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma Plasma, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 8, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 16, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1286076 - 2025-10-08
- FDA Inspection 1200223 - 2023-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.